Department of Pathology and Clinical Cytology, Central Hospital Falun, 79182, Falun, Sweden.
Virchows Arch. 2011 Feb;458(2):125-31. doi: 10.1007/s00428-010-1005-6. Epub 2010 Nov 3.
Early breast carcinoma, defined as purely in situ cancer and invasive carcinomas < 15 mm, represents the most frequent category of breast carcinomas in diagnostic routine in a regularly screened population. These tumors are usually detected with mammography screening and are preoperatively characterized with radiological imaging. The role of pathology in preoperative settings is to help understand the subgross morphology and to confirm malignancy in biopsy material. Postoperatively, the pathologist needs to verify the size of the cancer (defined as the largest dimension of the largest invasive focus), the extent of the disease (defined as the area or the volume of the breast tissue containing all the malignant foci), the distribution of the in situ and invasive lesions (as unifocal, multifocal, or diffuse), and intratumoral and intertumoral heterogeneity (in addition to determining margin status, histologic tumor type, hormone receptor status, and other parameters). Despite their small size, early breast carcinomas often exhibit complex morphology as they are multifocal/diffuse in about 60% and extensive (occupying an area ≥ 4 cm) in 40% of the cases. Routine use of large-format histopathology technique is a prerequisite for detailed correlation of the radiologic and histopathologic findings and for the correct assessment of these parameters. Breast pathologists must be aware of the advantages and disadvantages of the different imaging modalities and have detailed information about the radiological findings before work-up of the operative specimen. Multidisciplinary preoperative and postoperative tumor board meetings are essential in guiding the pathologists and in confirming the radiological findings. Interdisciplinary diagnosis is inevitably becoming the new gold standard in the diagnosis and management of early breast carcinomas.
早期乳腺癌,定义为纯粹的原位癌和浸润性癌 < 15 毫米,代表了在常规筛查人群的诊断常规中最常见的乳腺癌类别。这些肿瘤通常通过乳房 X 线筛查发现,并通过影像学进行术前特征描述。病理学在术前的作用是帮助理解大体形态,并在活检材料中确认恶性肿瘤。术后,病理学家需要验证癌症的大小(定义为最大浸润灶的最大直径)、疾病的范围(定义为包含所有恶性病灶的乳房组织区域或体积)、原位和浸润性病变的分布(单灶、多灶或弥漫性)以及肿瘤内和肿瘤间异质性(除了确定切缘状态、组织学肿瘤类型、激素受体状态和其他参数外)。尽管它们的体积较小,但早期乳腺癌通常表现出复杂的形态,因为它们在大约 60%的病例中是多灶性/弥漫性的,在 40%的病例中是广泛的(占据面积≥4 厘米)。常规使用大格式组织病理学技术是详细关联放射学和组织病理学发现以及正确评估这些参数的前提。乳腺病理学家必须了解不同成像方式的优缺点,并在处理手术标本之前详细了解放射学发现。多学科术前和术后肿瘤委员会会议对于指导病理学家和确认放射学发现至关重要。多学科诊断不可避免地成为早期乳腺癌诊断和管理的新标准。